Balentine LLC’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-11,770
| Closed | -$1.12M | – | 307 |
|
2024
Q1 | $1.12M | Buy |
11,770
+6,937
| +144% | +$663K | 0.03% | 173 |
|
2023
Q4 | $369K | Buy |
+4,833
| New | +$369K | 0.01% | 349 |
|
2023
Q3 | – | Sell |
-4,317
| Closed | -$407K | – | 574 |
|
2023
Q2 | $407K | Buy |
4,317
+1,173
| +37% | +$111K | 0.01% | 313 |
|
2023
Q1 | $260K | Buy |
+3,144
| New | +$260K | 0.01% | 456 |
|
2022
Q4 | – | Sell |
-4,816
| Closed | -$398K | – | 660 |
|
2022
Q3 | $398K | Buy |
4,816
+1,123
| +30% | +$92.8K | 0.02% | 331 |
|
2022
Q2 | $351K | Sell |
3,693
-810
| -18% | -$77K | 0.01% | 394 |
|
2022
Q1 | $530K | Buy |
4,503
+1,986
| +79% | +$234K | 0.02% | 282 |
|
2021
Q4 | $326K | Buy |
2,517
+461
| +22% | +$59.7K | 0.01% | 238 |
|
2021
Q3 | $233K | Buy |
+2,056
| New | +$233K | 0.01% | 216 |
|
2020
Q3 | – | Sell |
-576
| Closed | -$40K | – | 387 |
|
2020
Q2 | $40K | Buy |
576
+72
| +14% | +$5K | ﹤0.01% | 274 |
|
2020
Q1 | $32K | Sell |
504
-624
| -55% | -$39.6K | ﹤0.01% | 221 |
|
2019
Q4 | $88K | Buy |
1,128
+600
| +114% | +$46.8K | ﹤0.01% | 130 |
|
2019
Q3 | $39K | Buy |
528
+66
| +14% | +$4.88K | ﹤0.01% | 156 |
|
2019
Q2 | $28K | Buy |
462
+78
| +20% | +$4.73K | ﹤0.01% | 172 |
|
2019
Q1 | $24K | Hold |
384
| – | – | ﹤0.01% | 190 |
|
2018
Q4 | $20K | Hold |
384
| – | – | ﹤0.01% | 190 |
|
2018
Q3 | $22K | Buy |
+384
| New | +$22K | ﹤0.01% | 131 |
|
2018
Q1 | – | Sell |
-3,705
| Closed | -$139K | – | 215 |
|
2017
Q4 | $139K | Buy |
3,705
+870
| +31% | +$32.6K | 0.01% | 160 |
|
2017
Q3 | $103K | Buy |
2,835
+1,245
| +78% | +$45.2K | 0.01% | 182 |
|
2017
Q2 | $63K | Sell |
1,590
-741
| -32% | -$29.4K | 0.01% | 216 |
|
2017
Q1 | $73K | Buy |
2,331
+2,079
| +825% | +$65.1K | 0.01% | 191 |
|
2016
Q4 | $8K | Buy |
252
+54
| +27% | +$1.71K | ﹤0.01% | 423 |
|
2016
Q3 | $8K | Hold |
198
| – | – | ﹤0.01% | 377 |
|
2016
Q2 | $7K | Buy |
+198
| New | +$7K | ﹤0.01% | 382 |
|